University of Virginia School of Medicine

What University of Virginia School of Medicine does

The University of Virginia School of Medicine is a public academic medical institution founded in 1819 and operating as a component of the University of Virginia, governed by the Rector and Visitors. It delivers medical education across two campuses — the primary location in Charlottesville and a second campus at Inova in Falls Church, VA — and trains approximately 1,050 students (623 MD, 325 BIMS PhD, 102 Masters), 631 residents, and 216 fellows through 20 clinical departments. The school employs 1,436 faculty, including 3 Nobel laureates and 13 National Academy of Medicine members, and maintains a 99% residency match rate.

The school's research enterprise is anchored by $269M in annual funding, 198 NIH-funded principal investigators, and nine research departments spanning biomedical sciences, with a published NIH Blue Ridge ranking of 19th among public medical schools. Distinct research outputs include proprietary AI diffusion model tools (YuelDesign, YuelPocket, YuelBond) for drug design targeting the 90% clinical failure rate, a self-assembling polymer drug delivery system, and the discovery of a female-specific chimeric RNA (UBA1-CDK16) linked to severe COVID-19 outcomes. The institution holds LCME accreditation and operates a multi-channel research network including collaborations with Stanford, Weill Cornell, University of Minnesota, VCU, Virginia Tech, and Federal Medical Center Nigeria.

Revenue flows through three principal streams: federal research funding (primarily NIH), tuition and fees from educational programs, and clinical service revenue generated through UVA Health University Medical Center and the Inova Campus partnership. The school distributes research tools freely to the global scientific community as part of an open-science approach and conducts community outreach through the UVA Comprehensive Cancer Center and global health partnerships. Pricing for educational programs is set by the University of Virginia, and the institution does not disclose standalone revenue figures.

Name

University of Virginia School of Medicine

Legal name

University of Virginia School of Medicine

Website

https://med.virginia.edu

Company type

Private

Founded year

1819

Operating status

Operating

Short description

The University of Virginia School of Medicine is a public academic medical institution founded in 1819, training ~1,050 students and 847 GME trainees across Charlottesville and Inova campuses, conducting $269M in annual NIH-funded research, and operating clinical services through UVA Health.

Ownership category

akta.pro rank

Product category

Medical Education

NAICS

Colleges, Universities, and Professional Schools (6113), Colleges, Universities, and Professional Schools (611310)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro industry

PRIMARYEDAHAGAB

Medical Schools (MD/DO Granting)

Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities

SECONDARYEDAHAAAC

Public Research Universities with Academic Medical Centers (AMCs)

Education/Higher Education (Colleges & Universities)/Public Research Universities

SECONDARYEDAHAGAD

Schools of Public Health

Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities

SECONDARYEDAAALAC

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy)

Education/Adult & Continuing Education/Professional Licensure & Continuing Professional Education (CE/CPE)

Keywords

• Medical education
• Biomedical research
• Graduate medical education
• Clinical training
• Physician training

Headquarters

HQ city

Charlottesville

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Research Funding: NIH and other federal funding supporting biomedical research programs. The school receives $269M in research funding with 198 NIH-funded principal investigators.
2. Tuition and Fees: Medical education programs including MD program, graduate programs, and continuing education generate tuition revenue.
3. Patient Care Revenue: Clinical operations through UVA Health System providing patient care services.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

The University of Virginia School of Medicine is a public academic medical institution that delivers medical education (MD Program, BIMS PhD, master's, residency, fellowship, and continuing medical education), conducts biomedical and clinical research, and supports patient care delivery through the UVA Health System. It operates across two campuses in Charlottesville and Falls Church (Inova Campus), graduating physicians and scientists while running $269M in annual NIH-funded research.

Product overview

The University of Virginia School of Medicine offers a comprehensive portfolio of educational programs and research tools. The core educational offerings include the MD Program (with campuses in Charlottesville and Northern Virginia), the Biomedical Sciences Graduate Program (BIMS) PhD program, Graduate Medical Education (GME) with residency and fellowship training, the Summer Research Internship Program (SRIP) for undergraduates, and Continuing Medical Education. In the research domain, the school has developed a suite of AI-powered drug discovery tools consisting of YuelDesign, YuelPocket, and YuelBond that use diffusion models to address protein flexibility during drug binding. These tools are freely available to the global scientific community with the goal of reducing the 90% drug failure rate in human trials.

Differentiator

Problem solved

Functional benefit

Products and services

• MD Program

Quantifiable outcome

• 99% residency match rate demonstrating successful training outcomes
• +2 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature5 records

Partnerships

Ten partnerships are on record, tiered core, minor and major.

• Weill Cornell MedicinecoreStrategic or Co-development Partner · 18 February 2026Collaborative research study evaluating eight top-tier large language models for emergency care use, testing their ability to perform dynamic, multi-stage clinical reasoning under simulated emergency department workflows. Led by investigators from Weill Cornell Medicine and NewYork-Presbyterian in collaboration with Stanford University, University of Virginia, University of Minnesota, and other institutions.
• Stanford UniversitycoreStrategic or Co-development Partner · 18 February 2026Collaboration on study benchmarking LLMs for emergency department use, as part of multi-institutional research team.
• University of MinnesotacoreStrategic or Co-development Partner · 18 February 2026Collaboration on study benchmarking LLMs for emergency department use, as part of multi-institutional research team.
• Vita InnovationsminorStrategic or Co-development Partner · 18 February 2026Industry collaboration providing support for the study on LLM evaluation for emergency care use. Vita Innovations (CEO Longsha Liu) provides industry collaboration and expertise.
• Federal Medical Center NigeriamajorStrategic or Co-development Partner · 1 May 2025UVA Partners With Federal Medical Center in Nigeria to Elevate Global Kidney Care. Partnership focused on improving global kidney care through education, research collaboration, and clinical practice improvements.
• Manning Institute for BiotechnologycoreStrategic or Co-development PartnerMultiple research collaborations referenced with the Manning Institute for Biotechnology, including work on succinate signaling, B cell biology for lung disease, hyperpolarized xenon MRI for drug testing, cell state plasticity in cancer, microbiome-immune interactions in cancer, and Treg cell therapy development.
• Virginia Commonwealth University (VCU)coreStrategic or Co-development PartnerPartnership through T32 training program networking core fostering collaboration across the Commonwealth of Virginia, in partnership with UVA, VCU, Virginia Tech, and Virginia Health Sciences.
• Virginia TechcoreStrategic or Co-development PartnerPartnership through T32 training program networking core fostering collaboration across the Commonwealth of Virginia, in partnership with UVA, VCU, Virginia Tech, and Virginia Health Sciences.
• Virginia Health SciencescoreStrategic or Co-development PartnerPartnership through T32 training program networking core fostering collaboration across the Commonwealth of Virginia, in partnership with UVA, VCU, Virginia Tech, and Virginia Health Sciences.
• Inova Health SystemcoreStrategic or Co-development PartnerUVA School of Medicine Inova Campus partnership with Inova Health System in Falls Church, Virginia. The Inova Campus serves approximately 725 faculty and provides medical education for students in the Northern Virginia region.

Scale indicators14 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Johns Hopkins University School of Medicine: Top-tier US medical school with similar MD, PhD, residency, and NIH-funded research profile, operating its own academic medical center — directly comparable in mission, scale, and funding model.
• Duke University School of Medicine: Private research medical school with comparable MD program selectivity, NIH funding scale, and academic medical center operations, making it a close functional peer.
• University of Michigan Medical School: Large public medical school with AMC and significant NIH research portfolio; highly comparable to UVA as a public, research-intensive US medical school of similar scale.
• Weill Cornell Medicine: Ivy League medical school with an active multi-institutional research partnership with UVA (LLM benchmarking for emergency care), and similar MD/PhD/research portfolio.
• Stanford University School of Medicine: Elite research medical school and active UVA research collaborator on AI/LLM evaluation in emergency care; comparable in NIH funding scale and biomedical research output.
• Vanderbilt University School of Medicine: Private research medical school with comparable MD program, large residency/fellowship footprint, and significant NIH-funded research base.
• University of North Carolina School of Medicine: Public medical school with AMC operations and strong NIH funding, similar to UVA in public-institution structure and Southeast US regional footprint.
• Washington University School of Medicine in St. Louis: Top NIH-funded research medical school with comparable MD/PhD programs, large GME footprint, and biomedical research output.
• University of Minnesota Medical School: Public medical school and active UVA research collaborator (LLM evaluation study), with similar public-institution governance and research scale.
• Emory University School of Medicine: Private research medical school with comparable MD program selectivity, large GME portfolio, and substantial NIH research funding, anchored to a major AMC.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/medicineuva?lang=en
• YouTubeyoutube.com/channel/UCjF1Mkjn9mhT130qDBVLnPQ
• Facebookfacebook.com/Medicine.Virginia
• LinkedInlinkedin.com/company/university-of-virginia

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University of Virginia School of Medicine